| 14,15-EpETE/17,18-EpETE | 14,15-Epoxyeicosatetraenoic Acid/17,18-Epoxyeicosatetraenoic Acid |
| 14-HDHA/17-HDHA | 14-Hydroxydocosahexaenoic Acid/17-Hydroxydocosahexaenoic Acid |
| 5-HETE/12-HETE/12-HEPE/15-HEPE | 5-Hydroxyeicosatetraenoic Acid/12-Hydroxyeicosatetraenoic Acid/12-Hydroxyeicosapentaenoic Acid/15-Hydroxyeicosapentaenoic Acid |
| 5-oxo-ETE | 5-Oxo-Eicosatetraenoic Acid |
| AA | Arachidonic Acid |
| AC | Acne Comedonica |
| AD/AD-lika | Atopic dermatitis/Atopic dermatitis like |
| ALA | α-Linolenic Acid |
| ALX/FPR2 | Lipoxin A4 Receptor/Formyl Peptide Receptor 2 |
| AP | Acne Papulopustulosa |
| AT/ATL | Aspirin triggered/Aspirin triggered lipoxin |
| BALB/c | Bagg Albino Laboratory-bred Mouse Strain c |
| BLT1 | Leukotriene B4 Receptor 1 |
| BSA | Body Surface Area |
| CBMC | Cord blood mononuclear cell |
| CCL2 | C-C motif chemokine ligand 2 |
| CD80/86 | Co-stimulatory molecules expressed on antigen-presenting cells |
| CI | Confidence Interval |
| COX/COX-2/acetyl-COX-2 | Cyclooxygenase/Cyclooxygenase-2/aspirin-acetylated cyclooxygenase-2 |
| CRP | C-Reactive Protein |
| CTLA-4 | Cytotoxic T-lymphocyte-associated protein 4 |
| CYP-450 | Cytochrome P450 Enzyme System |
| CXCL10 | C-X-C motif chemokine ligand 10 |
| DGLA | Dihomo-γ-Linolenic Acid |
| DHA | Docosahexaenoic Acid |
| DHA-M2 | Docosahexaenoic acid–induced M2 macrophages |
| DHET | Dihydroxyeicosatrienoic Acid |
| DLQI | Dermatology Life Quality Index |
| DNCB | 2,4-dinitrochlorobenzene |
| DNFB | 2,4-dinitrofluorobenzene |
| DPA | Docosapentaenoic Acid |
| EASI | Eczema Area and Severity Index |
| ECM | Extracellular Matrix |
| ELOVL | Elongation of Very Long Chain Fatty Acids Protein (family) |
| EPA/EPA-E | Eicosapentaenoic Acid/eicosapentaenoic acid ethyl ester |
| ERK1/2 | Extracellular Signal–Regulated Kinases 1/2 |
| FAs | Fatty acids |
| FABP | Fatty Acid–Binding Protein |
| FADS2 | Fatty acid desaturase 2 |
| FDLQI | Family Dermatology Life Quality Index |
| FFA4R/GPR120 | Free Fatty Acid Receptor 4 |
| FK506 | Tacrolimus |
| FMT | Fecal Microbiota Transplantation |
| GLA | γ-linolenic acid |
| GPCR | G Protein–Coupled Receptor |
| HDL | High-density lipoprotein |
| HETE | Hydroxyeicosatetraenoic Acid |
| HEPE | Hydroxy-eicosapentaenoic Acid |
| HMGB | High-Mobility Group Box protein |
| HpEPE | Hydroperoxy-eicosapentaenoic Acid |
| HpETE | Hydroxyperoxy-eicosatetraenoic Acid |
| HR-AD | Hairless atopic dermatitis |
| HRO | Herring Roe Oil |
| HS | Hidradenitis Suppurativa |
| IgE | Immunoglobulin E |
| IL | Interleukin |
| IRI/I–R | Ischemia–Reperfusion Injury |
| ISAAC | International Study of Asthma and Allergies in Childhood |
| IV | Intravenous |
| IMQ | Imiquimod |
| KO | Knockout |
| LCE3B–C | Late Cornified Envelope Genes 3B and 3C |
| LC-PUFA | Long-chain polyunsaturated fatty acid |
| LN | Lymph node |
| LOX/5-LOX/12-LOX/15-LOX | Lipoxygenase/5- Lipoxygenase/12- Lipoxygenase/15- Lipoxygenase |
| LPL | Lipoprotein Lipase |
| LPS | Lipopolysaccharide |
| LT/LTA4/5/LTE4/5 | Leukotriene A4/5—E4/5 |
| LXA4/LXA5 | Lipoxin A4/A5 |
| M2 | Alternatively Activated Macrophage Phenotype |
| MAPK | Mitogen-Activated Protein Kinase |
| MaR1/MaR2 | Maresin-1/Maresin 2 |
| MCT | Medium-chain triglyceride |
| MCTR | Maresin Conjugates in Tissue Regeneration |
| MD | Mean difference |
| MR | Mendelian Randomization |
| MUFA | Monounsaturated fatty acid |
| NF-κB | Nuclear Factor kappa-light-chain-enhancer of activated B cells |
| NHDF | Normal Human Dermal Fibroblasts |
| NHEK | Normal Human Epidermal Keratinocytes |
| NK | Natural Killer Cells |
| NRF2 | Nuclear Factor Erythroid 2–Related Factor 2 |
| NSAID | Non-Steroidal Anti-Inflammatory Drug |
| PASI | Psoriasis Area and Severity Index |
| PAF | Platelet-activating factor |
| PBMC | peripheral blood mononuclear cell |
| PG/PGE2/PGE3/PGH2/PGG2 | Prostaglandin/E2/E3/H2/G2 |
| PGI2 | Prostacyclin |
| PSO | Psoriasis |
| PUFA | Polyunsaturated Fatty Acid |
| PD1 | Protectin D1 |
| PDX | Protectin DX |
| PLA2/PLA2G4E/sPLA2 | Phospholipase A2/Phospholipase A2 Group IVE/Secretory Phospholipase A2 |
| PPAR | Peroxisome Proliferator–Activated Receptor |
| PRS | Polygenic risk score |
| RCT | Randomized Controlled Trial |
| QoL | Quality of life |
| RvD1-RvD6 | Resolvin D1-D6 |
| RvE/RvE1–RvE4 | Resolvin E-series/E1/E2/E3/E4 |
| S100A12 | S100 Calcium-Binding Protein A12 |
| SCORAD | SCORing Atopic Dermatitis |
| SFA | Saturated fatty acid |
| SNP | Single-nucleotide polymorphism |
| SPMs | Specialized Pro-Resolving Mediators |
| SSS | Symptom Severity Score |
| STAT1 | Signal Transducer and Activator of Transcription 1 |
| TCM | Central Memory T cells |
| TCS | Topical corticosteroid |
| TEWL | Transepidermal Water Loss |
| TG | Trigliceride |
| TGF-β | Transforming growth factor-β |
| Th/Th2/Th17 | Helper T Cell/Type 2 Helper T Cell/Type 17 Helper T Cell |
| TN | Naïve T cells |
| TNF-α | Tumor Necrosis Factor α |
| Treg | Regulatory T cell |
| TSLP | Thymic stromal lymphopoietin |
| TXA2/TXB2 | Thromboxane A2/B2 |
| UFA | Unsaturated Fatty Acid |
| UV | Ultraviolet |
| VDR | Vitamin D Receptor |
| WT | Wild-Type |
| ω-3 | Omega-3 Fatty Acids |
| ω-6 | Omega-6 Fatty Acids |